Accelerated collagen-induced arthritis in IFN-γ receptor-deficient mice

Journal of Immunology

Volumn 158, Issue 11, 1997, Pages 5507-5513

  Vermeire, Kurt ^a   Heremans, Hubertine ^a   Vandeputte, Michel ^a   Huang, Sui ^b   Billiau, Alfons ^a   Matthys, Patrick ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; GAMMA INTERFERON RECEPTOR; INTERFERON RECEPTOR; INTERLEUKIN 2; INTERLEUKIN 4;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; GENETICS; IMMUNOLOGY; MOUSE; MOUSE MUTANT; RHEUMATOID ARTHRITIS;

ANIMALS; ARTHRITIS, RHEUMATOID; COLLAGEN; INTERLEUKIN-2; INTERLEUKIN-4; MICE; MICE, KNOCKOUT; RECEPTORS, INTERFERON;

EID: 0031156936     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Courtenay, J. S., M. J. Dallman, A. D. Dayan, A. Martin, and B. Mosedale. 1980. Immunisation against heterologous type II collagen induces arthritis in mice Nature 283:666.
2. Wooley, P. H., and J. M. Chapedelaine. 1987. Immunogenetics of collagen-induced arthritis. CRC Crit. Rev. Immunol. 8:1.
3. Feldmann, M., F. M. Brennan, and N. M. Ravinder. 1996. Role of cytokines in rheumatoid arthritis. Annu. Rev. Immunol. 14:397.
4. Lemmel, E. M., D. Brackertz, M. Franke, W. Gaus, P. W. Hartl, K. Machalke, H. Mielke, H. J. Obert, H. H. Peter, J. Sieper, R. Sprekeler, and H. Stierle. 1988. Results of a multicenter placebo-controlled double-blind randomized phase III clinical study of treatment of rheumatoid arthritis with recombinant interferon-gamma. Rheumatol. Int. 8:87.
5. Veys, E. M., H. Mielants, G. Verbruggen, J.-P. Grosclaude, W. Meyer, A. Galazka, and J. Schindler. 1988. Interferon gamma in rheumatoid arthritis: a double blind study comparing human recombinant interferon gamma with placebo. J. Rheumatol. 15:570.
6. Cannon, G. W., S. H. Pincus, R. D. Emkey, A. Denes, S. A. Cohen, F. Wolfe, P. A. Saway, A. M. Jaffer, A. L. Weaver, L. Cogen, and J. D. Schindler. 1989. Double-blind trial of recombinant gamma-interferon versus placebo in the treatment of rheumatoid arthritis. Arthritis Rheum. 32:964.
7. Mauritz, N. J., R. Holmdahl, R. Jonsson, P. H. Van Der Meide, A. Scheynius, and L. Klareskog. 1988. Treatment with gamma-iriterferon triggers the onset of collagen arthritis in mice. Arthritis Rheum. 31:1297.
8. Cooper, S. M., S. Sriram, and G. E. Ranges. 1988. Suppression of murine collagen-induced arthritis with monoclonal anti-Ia antibodies and augmentation with IFN-γ. J. Immunol. 141:1958.
9. Nakajima, H., H. Takamori, Y. Hiyama, and W. Tsukada. 1990. The effect of treatment with interferon-gamma on type II collagen-induced arthritis. Clin. Exp. Immunol. 81:441.
10. Williams, R. O., D. G. Williams, M. Feldmann, and R. N. Maini. 1993. Increased limb involvement in murine collagen-induced arthritis following treatment with anti-interferon-gamma. Clin. Exp. Immunol. 92:323.
11. Boissier, M.-C., G. Chiocchia, N. Bessis, J. Hajnal, G. Garotta, F. Nicoletti, and C. Fournier. 1995. Diphasic effect of interferon-γ in murine collagen-induced arthritis. Eur. J. Immunol. 25:1184.
12. Jacob, C. O., J. Holoshitz, P. Van Der Meide, S. Strober, and H. O. McDevitt. 1989. Heterogeneous effects of IFN-γ in adjuvant arthritis. J. Immunol. 142:1500.
13. Wiesenberg, I., P. H. Van Der Meide, H. Schellekens, and S. S: Alkan. 1989. Suppression and augmentation of rat adjuvant arthritis with monoclonal anti-interferon-gamma antibody. Clin. Exp. Immunol. 78:245.
14. Billiau, A. 1996. Interferon-γ in autoimmunity. Cytokine Growth Factors Rev. 7:25.
15. Fernandez-Botran, R., V. M. Sanders, T. R. Mosmann, and E. S. Vitetta. 1988. Lymphokine-mediated regulation of the proliferative response of clones of T helpers 1 and 2 cells. J. Exp. Med. 168:543.
16. Gajewski, T. F., and F. W. Fitch. 1988. Anti-proliferative effect of IFN-γ in immune regulation. I. IFN-γ inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones. J. Immunol. 140:4252.
17. Mosmann, T. R., and S. Sad. 1996. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today 17:138.
18. Andrews, H. J., R. A. D. Bunning, C. A. Dinarello, and R. G. G. Russell. 1989. Modulation of human chrondrocyte metabolism by recombinant human interferon-gamma: in vitro effects on basal and IL-1-stimulated proteinase production, cartilage degradation and DNA synthesis. Biochim. Biophys. Acta 128:134.
19. Huang, S., W. Hendriks, A. Althage, S. Hemmi, H. Bluethmann, R. Kamijo, J. Vilcek, R. M. Zinkemagel, and M. Aguet. 1993. Immune response in mice that lack the interferon-γ receptor. Science 259:1742.
20. Heremans, H., J. Van Damme, C. Dillen, R. Dijkmans, and A. Billiau. 1990. Interferon-γ, a mediator of lethal LPS-induced Shwartzman-like shock reactions in mice. J. Exp. Med. 171:1853.
21. Heremans, H., C. Dillen, M. Groenen, E. Martens, and A. Billiau. 1996. Chronic relapsing experimental autoimmune encephalomyelitis (CREAE) in mice: enhancement by monoclonal antibodies against interferon-γ. Eur. J. Immunol. 26: 2393.
22. Leo, O., M. Foo, D. H. Sacks, L. E. Samelson, and J. A. Bluestone. 1987. Identification of a mAb specific for a murine T3 polypeptide. Proc. Natl. Acad. Sci. USA 84:1374.
23. Peto, R., M. C. Pike, P. Armitage, N. E. Breslow, D. R. Cox, S. V. Howard, N. Mantel, and K. McPherson, J. Peto, and P. G. Smith. 1977. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Brit. J. Cancer 35:1.
24. Wooley, P. H., H. S. Luthra, J. M. Stuart, and C. S. David. 1981. Type II collagen-induced arthritis in mice: major histocompatibility complex (I region) linkage and antibody correlates. J. Exp. Med. 154:688.
25. Seki, N., Y. Sudo, T. Yoshioka, S. Sugihara, T. Fujitsu, S. Sakuma, T. Ogawa, T. Hamaoka, H. Senoh, and H. Fujiwara. 1988. Type II collagen-induced murine arthritis: induction and perpetuation of arthritis require synergy between humoral and cell-mediated immunity. J. Immunol. 140:1477.
26. Martens, E., C. Dillen, W. Put, H. Heremans, J. Van Damme, and A. Billiau. 1993. Increased circulating interleukin-6 (IL-6) activity in endotoxin-challenged mice pretreated with anti-IL-6 antibody is due to IL-6 accumulated in antigen-antibody complexes. Eur. J. Immunol. 23:2026.